awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33633424-92E8186D-14D6-4CCB-B252-27D234944F5A
Q33633424-92E8186D-14D6-4CCB-B252-27D234944F5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-92E8186D-14D6-4CCB-B252-27D234944F5A
Oral anticancer drugs: how limited dosing options and dose reductions may affect outcomes in comparative trials and efficacy in patients.
P2860
Q33633424-92E8186D-14D6-4CCB-B252-27D234944F5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33633424-92E8186D-14D6-4CCB-B252-27D234944F5A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4348b9bfecc1351499192d9273e048bd3f660e13
P2860
Sorafenib in advanced hepatocellular carcinoma